Pharmacare Premium Claims Pole Position On Pazopanib

Malta-Based Generics Developer Reports Two Successful Bioequivalence Trials

 
• By Dave Wallace
  
Advantage Leader Wooden Figures
Pharmacare Premium says it is leading the pack on pazopanib • Source: Alamy

More from Generics

More from Products